SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs admission of an affair and Nvidias independent investigation into reports that he was targeted by an alleged Chinese intelligence asset dominate discussion, with traders debating potential national-security and leadership risks. Bears fear fallout despite no confirmed compromise of company secrets, while bulls view the controversy as separate from Nvidias business and a buying opportunity.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,109,371. The last known price of Bitcoin is 75,663.53857906 USD and is down -0.17 over the last 24 hours. It is currently trading on 12776 active market(s) with $9,277,191,640.33 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff through closely watched support levels has fueled concern about further declines, with traders pointing to heavy selling and leveraged liquidations. The community is split between expecting a deeper breakdown and viewing the drop as a buying opportunity or bear trap, while proposed links to broader market weakness and geopolitical headlines remain speculative.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.16094256 USD and is down -1.49 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,342,393,155.38 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep decline alongside a broader crypto selloff is driving discussion, with traders watching the $1.10$1.20 area and debating whether it will hold. Some see the pullback as a buying opportunity, while others expect further losses; political uncertainty around crypto policy is also cited speculatively.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,197,894.00927157. The last known price of Ethereum is 2,232.83367397 USD and is down -0.19 over the last 24 hours. It is currently trading on 14283 active market(s) with $3,862,469,414.23 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is under pressure in a broad crypto selloff, with traders pointing to leveraged-long liquidations and wider risk-off sentiment; political and regulatory concerns are also cited, though their role is speculative. Bearish traders warn of further downside, while others are buying the dip and treating the decline as an accumulation opportunity.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,505.193803. The last known price of Zebec Network is 0.00179872 USD and is down -2.92 over the last 24 hours. It is currently trading on 133 active market(s) with $9,820,670.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Attention centers on Zebecs payroll and payments expansion, including MoneyGram/Stellar and European deployment developments, with traders debating whether growing adoption will translate into demand for ZBCN. Robinhood and Ripple-related claims are also fueling speculation, while skeptics point to weak price performance and question the tokens value capture.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

NNE is rebounding alongside other heavily sold-off small modular reactor stocks, prompting dip-buying and speculation about an oversold bounce or short covering. The community remains divided, with bullish traders citing nuclear power demand while skeptics point to the sectors prolonged slide and NNEs early-stage, pre-revenue profile.

Toshi (TOSHI) is a cryptocurrency launched in 2023and operates on the BNB Smart Chain (BEP20) platform. Toshi has a current supply of 420,689,980,957.1672248 with 420,658,160,155.40041346 in circulation. The last known price of Toshi is 0.00009751 USD and is down -1.72 over the last 24 hours. It is currently trading on 271 active market(s) with $2,368,303.26 traded over the last 24 hours. More information can be found at https://www.toshithecat.com/.

TOSHI

Dip-buying and hopes for a turnaround dominate TOSHI discussion, with holders adding after a prolonged decline while skeptics warn that further lows are possible. Traders are watching volume and chart resistance for a breakout, but no confirmed catalyst is driving the conversation.

Onyxcoin (XCN) is a cryptocurrency launched in 2021and operates on the Ethereum platform. Onyxcoin has a current supply of 53,402,422,627.32441369 with 40,401,002,518.96686512 in circulation. The last known price of Onyxcoin is 0.00342088 USD and is down -2.34 over the last 24 hours. It is currently trading on 205 active market(s) with $3,370,014.48 traded over the last 24 hours. More information can be found at https://onyx.org.

Onyxcoin

XCN is drawing attention for volatile price swings and renewed weakness alongside Bitcoin and the broader crypto market. Long-term holders are buying dips and blaming market-wide pressure, while skeptics point to repeated spikes and reversals as evidence of pump-and-dump behavior and fading momentum.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is drawing attention amid a sharp technology-sector correction and concerns that heavy AI and data-center spending may not generate adequate returns, alongside put-heavy options activity. Traders are split between expecting further weakness and viewing the pullback as a buying opportunity, with some describing it as sector rotation rather than a broader market breakdown.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention is centered on TG Therapeutics Q3 results and whether BRIUMVIs rapid sales growth can support its outlook; traders are also watching for updates on the subcutaneous BRIUMVI program. Many are bullish on the growth and speculate about a buyout or short squeeze, while others warn that expectations are elevated and strong results may already be priced in.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acumen Pharmaceuticals: 3 Key Takeaways for Long-Term Investors

Key PointsPhase II ALTITUDE-AD trial top-line results are expected in November 2026...

Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Acumen Pharmaceuticals Q3 2026 Earnings Call Transcript

Acumen Pharmaceuticals (NASDAQ:ABOS) reported third-quarter financial results on Monday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you byread more...

4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day

Four biotech stocks advance Alzheimer's therapies, from marketed treatments to experimental programs targeting amyloid and tau.

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?

Here is how Acumen Pharmaceuticals, Inc. (ABOS) and Amarin (AMRN) have performed compared to their sector so far this year.

All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy

Acumen Pharmaceuticals (ABOS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Are Medical Stocks Lagging  Acumen Pharmaceuticals (ABOS) This Year?

Acumen Pharmaceuticals (ABOS) Expected to Announce Quarterly Earnings on Tuesday

Acumen Pharmaceuticals (NASDAQ:ABOS) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-acumen-pharmaceuticals-inc-stock...

Short Interest in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Increases By 46.4%

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totaling 1,545,029 shares, an increase of 46.4% from the March 31st total of 1,055,415 shares. Approximately 2.4% of the...

Acumen Pharmaceuticals (NASDAQ:ABOS) Trading 0.7% Higher   - Still a Buy?

Acumen Pharmaceuticals (NASDAQ:ABOS) Shares Up 0.7% - Here's Why...

• Reported GAAP EPS of -$0.35 up 20.45% YoY
• Acumen Pharmaceuticals expects its $78.6M in cash, cash equivalents and marketable securities as of September 30, 2026, to support current clinical and operational activities into early 2027.

Acumen Pharmaceuticals reported $78.6M in cash and marketable securities versus $110.2M at June 30, G&A expenses of $4.7M versus $4.5M, and disclosed clinical-development and macroeconomic risks.

Acumen Pharmaceuticals expects ALTITUDE-AD topline results in November 2026, targets an EBD-program IND filing in mid-2027, and reports sabirnetug has FDA Fast Track designation and selectively targets soluble AOs.

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.

Acumen Pharmaceuticals Inc

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.2235
Prev Close	$0.2138
Open	$0.2121
Dividend Yield	0.00%
50-Day Moving Average	$2.12
Beta	4.31
Avg. Volume	3.78M
PE Ratio	-0.14

52-Week High	$3.60
52-Week Low	$0.1911
Market Capitalization	$16.17M
EPS (Annual)	-$2.00
Price to Book	0.47
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABOS Fundamentals